Heillose Zustände: Warum die Medizin die Menschen krank und das Land arm macht (German Edition)

Körperglück. Wie gute Gefühle gesund machen. München 2010
    Bartens W: Glücksmedizin. Was wirklich wirkt. München 2011
    Bastian H, Glasziou P, Chalmers I: Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med 2010;7:e1000326
    Beral V; Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419
    Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842
    Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008 Apr 16;(2):CD007176
    Boden WE: Mounting Evidence for Lack of PCI Benefit in Stable Ischemic Heart Disease: What More Will It Take to Turn the Tide of Treatment? Arch Intern Med 2012;172:319
    Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294:716
    Bröckling U: Das unternehmerische Selbst. Soziologie einer Subjektivierungsform. Frankfurt 2007
    Browman G, Hébert PC, Coutts J, Stanbrook MB, Flegel K, MacDonald NE: Personalized medicine: a windfall for science, but what about patients? CMAJ 2011;183:E1277
    Brown BG, Taylor AJ: Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? N Engl J Med 2008;358:1504
    Bruckenberger E: Herzbericht 2010
    Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B: A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009;361:557
    Cannon CP: Can the polypill save the world from heart disease? Lancet 2009;373:1313
    Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, Beard DJ: Knee replacement. Lancet 2012;379:1331
    Chou R, Fu R, Carrino JA, Deyo RA: Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet 2009;373:463
    Cohen D: How safe are metal-on-metal hip implants? BMJ 2012; 344:e1410
    De P, Neutel CI, Olivotto I, Morrison H: Breast cancer incidence and hormone replacement therapy in Canada. J Natl Cancer Inst 2010; 102:1489
    de Lorgeril M, Salen P, Abramson J, Dodin S, Hamazaki T, Kostucki W, Okuyama H, Pavy B, Rabaeus M: Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal. Arch Intern Med 2010;170:1032
    Dörner K: Gesundheitssystem: In der Fortschrittsfalle. Deutsches Ärzteblatt 2002;99:A2462
    Domenighetti G, Luraschi P, Casabianca A, Gutzwiller F, Spinelli A, Pedrinis E, Repetto F: Effect of information campaign by the mass media on hysterectomy rates. Lancet 1988;2:1470
    Domenighetti G, Casabianca A: Rate of hysterectomy is lower among female doctors and lawyers’ wives. BMJ 1997;314:1417
    Doshi P, Jefferson T, Del Mar C: The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience. PLoS Med 2012;9:e1001201.
    Doshi P, Jones M, Jefferson T: Rethinking credible evidence synthesis. BMJ 2012;344:d7898
    Drazen JM, Jarcho JA, Morrissey S, Curfman GD: Cholesterol lowering and ezetimibe. N Engl J Med 2008;358:1507
    Eichler H-G, Abadie E, Breckenridge A, Leufkens H, Rasi G: Open Clinical Trial Data for All? A View from Regulators. PLoS Med 2012; 9:e1001202
    Ellis SG: Refining the art and science of coronary stenting. N Engl J Med 2009;360:292
    Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B: Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:c4737
    Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010;303:235
    Flintrop J: Boni für Chefärzte: Bedenkliche Anreize – Immer mehr Chefarztverträge enthalten Zielvereinbarungen. Dabei werden vorrangig finanzielle Ziele festgelegt. Deutsches Ärzteblatt 2012;109: A298
    Fojo T, Grady C: How much is life worth: cetuximab, non-small cell lung cancer, and the $ 440 billion question. J Natl Cancer Inst 2009; 101:1044
    Fried TR, Tinetti ME, Towle V, O’Leary JR, Iannone L: Effects of benefits and harms on